These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Wilms tumor and the WT1 gene. Lee SB; Haber DA Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525 [TBL] [Abstract][Full Text] [Related]
23. Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Inoue K; Tamaki H; Ogawa H; Oka Y; Soma T; Tatekawa T; Oji Y; Tsuboi A; Kim EH; Kawakami M; Akiyama T; Kishimoto T; Sugiyama H Blood; 1998 Apr; 91(8):2969-76. PubMed ID: 9531608 [TBL] [Abstract][Full Text] [Related]
24. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Inoue K; Ogawa H; Sonoda Y; Kimura T; Sakabe H; Oka Y; Miyake S; Tamaki H; Oji Y; Yamagami T; Tatekawa T; Soma T; Kishimoto T; Sugiyama H Blood; 1997 Feb; 89(4):1405-12. PubMed ID: 9028964 [TBL] [Abstract][Full Text] [Related]
25. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program. Svedberg H; Chylicki K; Baldetorp B; Rauscher FJ; Gullberg U Oncogene; 1998 Feb; 16(7):925-32. PubMed ID: 9484784 [TBL] [Abstract][Full Text] [Related]
26. Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). Tsuboi A; Oka Y; Ogawa H; Elisseeva OA; Tamaki H; Oji Y; Kim EH; Soma T; Tatekawa T; Kawakami M; Kishimoto T; Sugiyama H Leuk Res; 1999 May; 23(5):499-505. PubMed ID: 10374864 [TBL] [Abstract][Full Text] [Related]
27. Human cytotoxic T lymphocytes specific for Wilms' tumor antigen-1 inhibit engraftment of leukemia-initiating stem cells in non-obese diabetic-severe combined immunodeficient recipients. Gao L; Xue SA; Hasserjian R; Cotter F; Kaeda J; Goldman JM; Dazzi F; Stauss HJ Transplantation; 2003 May; 75(9):1429-36. PubMed ID: 12792492 [TBL] [Abstract][Full Text] [Related]
28. Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1. Rae FK; Martinez G; Gillinder KR; Smith A; Shooter G; Forrest AR; Grimmond SM; Little MH Oncogene; 2004 Apr; 23(17):3067-79. PubMed ID: 15021918 [TBL] [Abstract][Full Text] [Related]
29. Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome. Busse A; Gökbuget N; Siehl JM; Hoelzer D; Schwartz S; Rietz A; Thiel E; Keilholz U Ann Hematol; 2009 Dec; 88(12):1199-205. PubMed ID: 19404640 [TBL] [Abstract][Full Text] [Related]
30. Wilms' tumor 1 is involved in tumorigenicity of glioblastoma by regulating cell proliferation and apoptosis. Kijima N; Hosen N; Kagawa N; Hashimoto N; Kinoshita M; Oji Y; Sugiyama H; Yoshimine T Anticancer Res; 2014 Jan; 34(1):61-7. PubMed ID: 24403445 [TBL] [Abstract][Full Text] [Related]
31. A tumor suppressor and oncogene: the WT1 story. Yang L; Han Y; Suarez Saiz F; Minden MD Leukemia; 2007 May; 21(5):868-76. PubMed ID: 17361230 [TBL] [Abstract][Full Text] [Related]
32. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors. Udtha M; Lee SJ; Alam R; Coombes K; Huff V Oncogene; 2003 Jun; 22(24):3821-6. PubMed ID: 12802290 [TBL] [Abstract][Full Text] [Related]
33. Identification of a gene element essential for leukemia-specific expression of transgenes. Hosen N; Yanagihara M; Nakazawa T; Kanato K; Nishida S; Shirakata T; Asada M; Masuda T; Taniguchi Y; Kawakami M; Tsuboi A; Ikegame K; Oka Y; Ogawa H; Kawase I; Oji Y; Sugiyama H Leukemia; 2004 Mar; 18(3):415-9. PubMed ID: 14737070 [TBL] [Abstract][Full Text] [Related]
34. An isoform of the Wilms' tumor suppressor gene potentiates granulocytic differentiation. Loeb DM; Summers JL; Burwell EA; Korz D; Friedman AD; Sukumar S Leukemia; 2003 May; 17(5):965-71. PubMed ID: 12750711 [TBL] [Abstract][Full Text] [Related]
35. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells. Takeda A; Goolsby C; Yaseen NR Cancer Res; 2006 Jul; 66(13):6628-37. PubMed ID: 16818636 [TBL] [Abstract][Full Text] [Related]
36. Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells. Miyagi T; Ahuja H; Kubota T; Kubonishi I; Koeffler HP; Miyoshi I Leukemia; 1993 Jul; 7(7):970-7. PubMed ID: 8321047 [TBL] [Abstract][Full Text] [Related]
37. Cyclin A1 regulates WT1 expression in acute myeloid leukemia cells. Krug U; Yasmeen A; Beger C; Bäumer N; Dugas M; Berdel WE; Müller-Tidow C Int J Oncol; 2009 Jan; 34(1):129-36. PubMed ID: 19082485 [TBL] [Abstract][Full Text] [Related]
38. Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation. Lu L; Ge Y; Li ZH; Xiao M; Broxmeyer HE Exp Hematol; 1996 Feb; 24(2):347-51. PubMed ID: 8641364 [TBL] [Abstract][Full Text] [Related]
39. Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies. Miyagawa K; Hayashi Y; Fukuda T; Mitani K; Hirai H; Kamiya K Genes Chromosomes Cancer; 1999 Jun; 25(2):176-83. PubMed ID: 10338002 [TBL] [Abstract][Full Text] [Related]
40. Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells. Ullmark T; Montano G; Järvstråt L; Jernmark Nilsson H; Håkansson E; Drott K; Nilsson B; Vidovic K; Gullberg U Biochem Biophys Res Commun; 2017 Jan; 482(4):802-807. PubMed ID: 27889611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]